Literature DB >> 11292785

Dissociation of infectivity and pathogenicity in Borrelia burgdorferi.

V Thomas1, J Anguita, S Samanta, P A Rosa, P Stewart, S W Barthold, E Fikrig.   

Abstract

Clonal Borrelia burgdorferi N40 (cN40) passaged 75 times in vitro (N40-75) infects mice but does not cause disease. N40-75 passaged 45 times further in vitro (N40-120) was no longer infectious and lacked genes encoded on linear plasmids 38 and 28-1, among other differences. These data suggest that B. burgdorferi cN40, N40-75, and N40-120 have distinct phenotypes that can be used to dissect the genetic elements responsible for pathogenicity and infectivity.

Entities:  

Mesh:

Year:  2001        PMID: 11292785      PMCID: PMC98321          DOI: 10.1128/IAI.69.5.3507-3509.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Correlation between plasmid content and infectivity in Borrelia burgdorferi.

Authors:  J E Purser; S J Norris
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

2.  Lyme borreliosis in selected strains and ages of laboratory mice.

Authors:  S W Barthold; D S Beck; G M Hansen; G A Terwilliger; K D Moody
Journal:  J Infect Dis       Date:  1990-07       Impact factor: 5.226

3.  Induction of an outer surface protein on Borrelia burgdorferi during tick feeding.

Authors:  T G Schwan; J Piesman; W T Golde; M C Dolan; P A Rosa
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

4.  Protection of C3H/HeN mice from challenge with Borrelia burgdorferi through active immunization with OspA, OspB, or OspC, but not with OspD or the 83-kilodalton antigen.

Authors:  W S Probert; R B LeFebvre
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

5.  An OspB mutant of Borrelia burgdorferi has reduced invasiveness in vitro and reduced infectivity in vivo.

Authors:  A Sadziene; A G Barbour; P A Rosa; D D Thomas
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

6.  Low-passage-associated proteins of Borrelia burgdorferi B31: characterization and molecular cloning of OspD, a surface-exposed, plasmid-encoded lipoprotein.

Authors:  S J Norris; C J Carter; J K Howell; A G Barbour
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

7.  High- and low-infectivity phenotypes of clonal populations of in vitro-cultured Borrelia burgdorferi.

Authors:  S J Norris; J K Howell; S A Garza; M S Ferdows; A G Barbour
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

8.  Analysis of the distribution and molecular heterogeneity of the ospD gene among the Lyme disease spirochetes: evidence for lateral gene exchange.

Authors:  R T Marconi; D S Samuels; R K Landry; C F Garon
Journal:  J Bacteriol       Date:  1994-08       Impact factor: 3.490

9.  Relationship between infectivity and OspC expression in Lyme disease Borrelia.

Authors:  T Masuzawa; T Kurita; H Kawabata; Y Yanagihara
Journal:  FEMS Microbiol Lett       Date:  1994-11-01       Impact factor: 2.742

10.  Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine.

Authors:  A M de Silva; S R Telford; L R Brunet; S W Barthold; E Fikrig
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

View more
  14 in total

1.  The BBA01 protein, a member of paralog family 48 from Borrelia burgdorferi, is potentially interchangeable with the channel-forming protein P13.

Authors:  Marija Pinne; Katrin Denker; Elin Nilsson; Roland Benz; Sven Bergström
Journal:  J Bacteriol       Date:  2006-06       Impact factor: 3.490

Review 2.  Lyme Borreliosis: Is there a preexisting (natural) variation in antimicrobial susceptibility among Borrelia burgdorferi strains?

Authors:  Emir Hodzic
Journal:  Bosn J Basic Med Sci       Date:  2015-07-08       Impact factor: 3.363

3.  Borrelia burgdorferi linear plasmid 38 is dispensable for completion of the mouse-tick infectious cycle.

Authors:  Daniel P Dulebohn; Aaron Bestor; Ryan O M Rego; Philip E Stewart; Patricia A Rosa
Journal:  Infect Immun       Date:  2011-06-27       Impact factor: 3.441

4.  Borrelia burgdorferi-induced inflammation facilitates spirochete adaptation and variable major protein-like sequence locus recombination.

Authors:  J Anguita; V Thomas; S Samanta; R Persinski; C Hernanz; S W Barthold; E Fikrig
Journal:  J Immunol       Date:  2001-09-15       Impact factor: 5.422

5.  Borrelia burgdorferi changes its surface antigenic expression in response to host immune responses.

Authors:  Fang Ting Liang; Jun Yan; M Lamine Mbow; Steven L Sviat; Robert D Gilmore; Mark Mamula; Erol Fikrig
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

6.  The luxS gene is not required for Borrelia burgdorferi tick colonization, transmission to a mammalian host, or induction of disease.

Authors:  Jon S Blevins; Andrew T Revel; Melissa J Caimano; Xiaofeng F Yang; James A Richardson; Kayla E Hagman; Michael V Norgard
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

7.  The failure of immune response evasion by linear plasmid 28-1-deficient Borrelia burgdorferi is attributable to persistent expression of an outer surface protein.

Authors:  Monica E Embers; Xavier Alvarez; Tara Ooms; Mario T Philipp
Journal:  Infect Immun       Date:  2008-07-14       Impact factor: 3.441

8.  Plasmid stability during in vitro propagation of Borrelia burgdorferi assessed at a clonal level.

Authors:  Dorothee Grimm; Abdallah F Elias; Kit Tilly; Patricia A Rosa
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

9.  Passage through Ixodes scapularis ticks enhances the virulence of a weakly pathogenic isolate of Borrelia burgdorferi.

Authors:  Sarojini Adusumilli; Carmen J Booth; Juan Anguita; Erol Fikrig
Journal:  Infect Immun       Date:  2009-10-12       Impact factor: 3.441

10.  Linear and circular plasmid content in Borrelia burgdorferi clinical isolates.

Authors:  Radha Iyer; Ogori Kalu; Joye Purser; Steven Norris; Brian Stevenson; Ira Schwartz
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.